• AstraZeneca Q4 Profit Rises; Revenue Ex COVID-19 Up 16% At CER

    Source: NASDAQ US Markets / 08 Feb 2024 01:49:12   America/Chicago

    (RTTNews) - AstraZeneca PLC (AZN.L, AZN) reported that its fourth quarter profit to owners of the parent increased to $960 million from $901 million, prior year. Earnings per $0.25 ordinary share was $0.62 compared to $0.58. Core EPS was $1.45, up 7% at CER. https://www.nasdaq.com/articles/astrazeneca-q4-profit-rises-revenue-ex-covid-19-up-16-at-cer
Share on,